Abstract: An exemplary method includes detecting two or more event interval times associated with an arrhythmic condition, averaging event interval times to provide an average event interval time, providing a fraction and calling for delivery of an anti-arrhythmia shock at a delivery time based on the fraction and the average event interval time. In this exemplary method, the events optionally correspond to early coarse ventricular fibrillation events and the delivery time is optionally less than about three seconds from the detecting of a first event of a first event interval time. Other exemplary methods, devices, systems, etc., are also disclosed.

Abstract: Diagnosing a patient's cardiac health through the use of parameter change analysis involves a system that includes an implantable cardiac device to sense a parameter related to a patient's heart. The system further includes a parameter change detection sub-system configured to derive a trend of the parameter over time and to detect changes to the trend. The trend and detected changes can then be used to diagnose changes in the patient's cardiac health. Results of the diagnosis are stored and presented to a care physician.

Abstract: A unitary subcutaneous implantable cardioverter-defibrillator has a long thin housing in the shape of a patient's rib. The housing contains a source of electrical energy, a capacitor, and operational circuitry that senses the presence of potentially fatal heart rhythms. Provided on the housing are cardioversion/defibrillation electrodes located to deliver electrical cardioversion-defibrillation energy when the operational circuitry senses a potentially fatal heart rhythm. The unitary subcutaneous implantable cardioverter-defibrillator does not have a transvenous, intracardiac, epicardial, or subcutaneous electrode.

Abstract: A computer software program is described that maps the electrical activity of a patient's heart. The software program utilizes inputs from electrodes contained within a heart chamber. Inputs from the electrodes cause the program to calculate the heart chamber volume, and then to determine the position of the electrodes within the heart chamber. The program then utilizes inputs from the electrodes to calculate the three-dimensional volumetric electrical field distribution of said heart chamber. This calculation is accomplished using a spherical harmonic series expression. Finally, the computer program displays the electrical field distribution of the heart chamber.

Abstract: A system and method for transcutaneous energy transfer and/or charging in a transverse direction. An external power source having a primary coil being driven at a frequency selectable in the range between eight and twelve kiloHertz contained in a housing. An implantable medical device has componentry for providing a therapeutic output and a secondary coil operatively coupled to the componentry. The external power source is capable of providing energy to the implantable medical device when the primary coil of the external power source is placed in proximity of the secondary coil of the implantable medical device. The external power source has a lateral positional adjustment for the primary coil. The frequency of the external power source is frequency adjustable providing a frequency adjustment.

Abstract: External power source, and system and method using such external power source, for an implantable medical device having therapeutic componentry and a secondary coil operatively coupled to the therapeutic componentry. A primary coil is capable of inductively energizing the secondary coil when externally placed in proximity of the secondary coil. A repositionable magnetic core associated with the primary coil is capable of being repositioned by a user of the external power source. An indicator is capable of providing the user with information relative to coupling between the primary coil and the secondary coil as a function of repositioning of the repositionable magnetic core.

Abstract: Methods and electronic tools for imaging a chest region of a patient and communicating with a heart stimulation device used by the patient are disclosed. The electronic tool may include a communications device for two-way data transmission of signals encoded with information to and from the heart stimulation device. The tool may also include an imaging device for radiating energy onto the chest of the patient and receiving energy as it is reflected from the chest region to produce an image signal. The tool may include a display screen for showing an image of the chest area and/or the information received from the heart stimulation device. The tool may also include a processor for formulating and/or analyzing information sent to and/or received from the heart stimulation device. One method of using the electronic tool includes analyzing the image signal and/or received information to provide instructions to the heart stimulation device.

Abstract: A capture detection algorithm detects and distinguishes atrial capture. Atrial chamber reset (ACR) and AV conduction (AVC) algorithms are implemented to measure an atrial pacing threshold The data that is used to choose between ACR and AVC methods is used to determine the progression of the patient's disease state. Some of the significant aspects of the invention include enablement of accurate threshold measurements, including calculation of stability criteria, precise interval measurements and the use of reference interval to determine capture and loss of capture.

Abstract: According to embodiments of the invention, one or more implants in a body may be connected with optical fibers for transmitting data and/or power to or from the implants. Aspects of the invention related to various embodiments of the actual implant as well as to various embodiments for connecting optical fibers to the implants.

Abstract: A method and apparatus for placing an epicardial lead over a desired, predetermined location on the left ventricle using a minimally invasive approach. A thoracoscope having a handle portion and a probe tube defining a central opening is placed through an incision in the patient generally aligned with the desired position for the pacing lead. An introducer and pacing lead are placed within the central opening of the thoracoscope and moved into contact with the pericardium at the desired lead location. An attachment member of the pacing lead attaches an electrode of the pacing lead to the pericardium. The pacing lead includes a mesh disk surrounding the electrode to aid in long term attachment of the electrode to the heart. Alternatively, the pericardium can be incised such that the lead is placed directly over the epicardial surface of the left ventricle.

Abstract: An implantable cardiac stimulation device treats apnea with either phrenic nerve stimulation pulses or cardiac stimulation pulses. The device includes an apnea detector that detects apnea of a patient, a blood oxygen saturation monitor that measures a blood oxygen saturation level of the patient responsive to detection of apnea, and a tiered therapy circuit that provides phrenic nerve stimulation pulses if the measured blood oxygen saturation level is within a first range and cardiac stimulation pulses if the measured blood oxygen saturation level is within a second range. The cardiac stimulation pulses are preferably provided in a DAO pacing mode.

Abstract: An electrode assembly (10) for a portable ECG signaling device, comprises a thin, flexible electrode support (11) supporting thereon a plurality of electrodes in spaced relationship. The electrodes (V1, V2, V3, V4, V5 and V6, LA, RA, LL) are configured for producing a twelve-lead electrocardiogram, and the electrode assembly is foldable into a compact assembly when not in use.

Abstract: An implantable ischemia detecting devices generates a plurality of electrograms for analysis. A processor integrates the ST segment and T wave of each electrogram and normalizes the resulting integral by a normalizing factor to provide a ST segment score and T wave score, respectively. The ST segment and T wave scores are then utilized to compute a total ST segment and T wave score for analysis in detecting or monitoring ischemia of a patient's heart.

Abstract: Electrode assemblies are provided, in which a pair of electrodes is joined by a central member. In some implementations, the electrode assemblies are foldable, and are configured to facilitate correct placement on a patient's chest. Some electrode assemblies include a separable electrode, allowing the electrode assembly to be fitted to patients having particularly large chests.

Abstract: A method for treatment and modification of material including biological material using an electromagnetic energy source directed to apply the energy to a region of the material, so as to modify and treat a portion of the material in the region. Preferably, an interaction-modifying substance is in the treated region prior to the interaction.

Abstract: A lead having an extendable and retractable fixation mechanism has a rotating terminal pin at the terminal end which rotates the fixation mechanism at the distal end. As the terminal pin is rotated, the fixation mechanism is extended or retracted from the distal end of the lead. A threaded collar allows for the fixation mechanism to smoothly extend and retract from the lead, and allows for a 1:1 turn ratio between the terminal pin and the fixation mechanism. A fluoroscopic ring disposed at the distal end of the lead provides information during the implantation process.

Abstract: A lead comprising both a main lead and a transverse lead. The main lead includes a main lead body with a longitudinal axis and at least one electrode. The Transverse lead includes a transverse lead body and at least one electrode, where the transverse lead body extends laterally from the main lead body and curves around the longitudinal axis of the main lead body to partially encircle at least a portion of the main lead. In one embodiment, the transverse lead is adapted to press the at least one electrode on the transverse lead against endocardial tissue. At least a portion of the main lead and at least a portion of the transverse lead are both adapted to be housed within and pass through an implant catheter. In an alternative embodiment, there is a lead system which comprises a first lead and a second lead, where the second lead includes a sleeve, where the first lead is adapted to move through the sleeve to attach the first lead to the second lead.

Abstract: An implantable medical device such as a cardiac pacemaker or implantable cardioverter/defibrillator with the capability of receiving communications in the form of speech spoken by the patient. An acoustic transducer is incorporated within the device which along with associated filtering circuitry enables the voice communication to be used to affect the operation of the device or recorded for later playback.

Abstract: An instrument and method for imaging and localizing of electrical activities in a biological system, comprising a plurality of sensors for detecting signals over a part of a surface of the biological system, a data acquisition unit for collecting the signals, a positioning device for determining positions of the sensors, a procedure for determining geometry information of the biological system, an electrical source model incorporating physical and physiological properties of the biological system, an estimator for determining the parameters of the electrical source model, and a unit for displaying the reconstructed excitation sequence and/or electrical source distribution in the three dimension space of the biological system and over time.

Abstract: A method and system for ventricular defibrillation by coordinating the delivery of defibrillation shocks with sensed ventricular fibrillation complexes in a way which improves the probability of success of the defibrillation shock. Ventricular electrical activity is monitored in two ventricular locations during ventricular fibrillation to detect coarse ventricular fibrillation complexes and contractions of the ventricular cardiac tissue. The defibrillation shock is delivered in coordination with the occurrence of coarse ventricular fibrillation complexes and the contractions of ventricular cardiac tissue, and specifically to occur on the up-slope portion thereof, for optimal probability of success.